Table 4 sP-selectin and C-reactive protein serum levels among patients and controls
From: Impact of obstructive sleep apnea on platelet activation and development of silent brain infarctions
Mild (n = 5) | Moderate (n = 8) | Severe (n = 11) | Controls (n = 24) | Test of sig | p | |
|---|---|---|---|---|---|---|
sP-selectin (ng/ml) | ||||||
Normal (1–140) | 5 (100%) | 4 (50%) | 2 (18.2%) | 24 (100%) | χ2 = 29.419* | MCp < 0.001* |
> 140 | 0 (0%) | 4 (50%) | 9 (81.8%) | 0 (0%) | ||
Mean ± SD | 78.60 ± 51.18 | 133.25 ± 53.78 | 261.27 ± 106.77 | 62.50 ± 45.76 | H = 25.631* | < 0.001* |
Median (min.–max.) | 80 (25–138) | 147.5 (48–201) | 280 (96–450) | 65.0 (1.0–135.0) | ||
C-reactive protein | ||||||
< 6 negative | 4 (80.0%) | 4 (50.0%) | 0 (0.0%) | 24 (100.0%) | χ2 = 38.777* | MCp < 0.001* |
≥ 6 positive | 1 (20.0%) | 4 (50.0%) | 11 (100.0%) | 0 (0.0%) | ||
Mean ± SD | 4.80 ± 4.49 | 7.88 ± 4.45 | 15.27 ± 3.77 | 2.67 ± 1.88 | H = 29.718* | < 0.001* |
Median (min.–max.) | 5.0 (1.0–12.0) | 7.50 (2.0–16.0) | 16.0 (7.0–19.0) | 2.50 (0.0–5.0) | ||